Zhitong Finance App News, HiCisco (002653.SZ) issued an announcement. The company recently received the “Drug Clinical Trial Approval Notice” issued by the State Drug Administration. After review, the HSK60002 tablets accepted in July 2026 met the relevant requirements for drug registration and agreed to carry out clinical trials with this product.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.